New Key Statistics Module, Z-Score and F-Score
SZSE:002868 Key Ratios
Market Cap ¥ M | 2,649.84 |
Enterprise Value ¥ M | 3,630.47 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 6.96 |
Price/Sales | 4.65 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 567.00 |
EPS (TTM) ¥ | -1.57 |
Beneish M-Score | -2.65 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -16.43 |
EV-to-EBITDA | -16.43 |
PEG | -- |
Shares Outstanding M | 155.42 |
Net Margin (%) | -42.84 |
Operating Margin % | -24.51 |
Pre-tax Margin (%) | -47.60 |
Quick Ratio | 0.26 |
Current Ratio | 0.51 |
ROA % (ttm) | -14.82 |
ROE % (ttm) | -49.83 |
ROIC % (ttm) | -8.06 |
Dividend Yield % | -- |
Altman Z-Score | 0.58 |
SZSE:002868 Number of Guru Trades
SZSE:002868 Volume of Guru Trades
Gurus Latest Trades with SZSE:002868
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002868 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Lifecome Biochemistry Co Ltd Insider Transactions
No Available Data